Welcome to our dedicated page for Orthopedia news (Ticker: KIDS), a resource for investors and traders seeking the latest updates and insights on Orthopedia stock.
OrthoPediatrics Corp. (NASDAQ: KIDS) is an orthopedic medical device company focused exclusively on pediatric orthopedics, and its news flow reflects this specialization. Company announcements frequently cover revenue updates, financial guidance, and quarterly earnings, where OrthoPediatrics discusses performance across its trauma and deformity, scoliosis, and specialty bracing (OPSB) product lines, as well as metrics such as the number of children treated with its systems.
Readers following KIDS news can expect regular updates on financial results and outlook, including preliminary unaudited revenue releases, full quarterly earnings reports, and adjustments to annual guidance. These releases often highlight contributions from specific product categories, trends in domestic and international revenue, and management’s commentary on operational initiatives such as restructuring efforts and cost management.
OrthoPediatrics also issues news on product development and regulatory milestones. Recent examples include FDA approval of the 3P Pediatric Plating Platform Small-Mini System, additional FDA clearances within a single year, and EUMDR certification for spine, trauma, and deformity implants and instruments. The company reports on first clinical procedures with new systems, such as the VerteGlide Spinal Growth Guidance System for early onset scoliosis, and on portfolio expansions like new PediHip bracing products within OPSB.
In addition, KIDS news includes strategic and corporate updates, such as distribution partnerships (for example, with MY01 for Continuous Perfusion Sensing Technology), expansion of OPSB clinics and territories, participation in healthcare and investor conferences, and changes to the board of directors. Investors and observers who monitor this news stream gain insight into how OrthoPediatrics is evolving its pediatric orthopedic platform, broadening its product offering, and engaging with clinicians and the capital markets.
OrthoPediatrics Corp. (Nasdaq: KIDS) announced preliminary unaudited revenue for Q4 and full year 2021. Q4 revenue is estimated at $24.8 million, a 31% increase from Q4 2020's $18.9 million. Domestic revenue rose 11%, while international revenue surged 363%. Full year 2021 revenue is expected to reach $98.0 million, reflecting 38% growth. Domestic sales grew 24%, and international sales increased 150%. The final financial results will be released in March 2022, as these figures are subject to audit adjustments.
Telos Partners LLC, a subsidiary of OrthoPediatrics Corporation (NASDAQ: KIDS), has appointed Scott Day as Senior VP and General Manager. This follows the leadership of Jason Inzana, who established a strong foundation for predictable revenue. Since the acquisition, Telos has doubled its team and expanded its client base, positioning itself for growth amid industry challenges. Day, with a successful track record in medical technology, aims to lead Telos through an aggressive growth phase while ensuring high-quality outcomes for clients.
OrthoPediatrics Corp. (NASDAQ: KIDS) recently reaffirmed its commitment as a Double-Diamond sponsor of the International Pediatric Orthopaedic Symposium (IPOS) held from December 7 to 11 in Orlando, Florida, attracting over 400 pediatric orthopedic surgeons. CEO David Bailey emphasized the value of in-person connections and the company's enduring partnership with the Pediatric Orthopedic Society of North America (POSNA). Furthermore, OrthoPediatrics showcased its expanding portfolio, including exclusive technologies like ApiFix and 7D Flash Intraoperative Navigation, aimed at enhancing pediatric orthopedic practices.
OrthoPediatrics Corp (Nasdaq: KIDS) announced its participation in the 33rd Annual Piper Sandler Virtual Healthcare Conference with a fireside chat webcast featuring CEO Dave Bailey and COO Fred Hite. This event will include 1x1 investor meetings scheduled for December 1, 2021, accessible exclusively through Piper Sandler. Additionally, the audio webcast will be available on OrthoPediatrics' investor relations website until December 2, 2021. OrthoPediatrics specializes in pediatric orthopedics, offering 36 surgical systems to enhance care for children with orthopedic conditions.
OrthoPediatrics Corp. (KIDS) reported a third quarter 2021 revenue of $25.1 million, a 13% increase from $22.2 million in Q3 2020. Domestic revenue fell 1% to $19.4 million, while international revenue surged 118% to $5.7 million. Trauma and Deformity revenue was up 12%, Scoliosis revenue grew 11%, and Sports Medicine/Other revenue rose 46%. The company maintained its full-year revenue guidance of $97-$101 million, projecting 36% to 42% growth over 2020. Net loss narrowed to $2.2 million from $4.5 million year-on-year.
OrthoPediatrics Corp (Nasdaq: KIDS) will have key executives participating in a fireside chat at the Stifel 2021 Virtual Healthcare Conference on November 15, 2021, at 10:00 AM ET. The executives include President & CEO Dave Bailey, COO and CFO Fred Hite, and Executive Chairman Mark Throdahl. The event will feature a webcast format and include one-on-one meetings. An audio replay of the presentation will be made available for 90 days on the company's investor relations website, showcasing their dedicated focus on pediatric orthopedic advancements.
OrthoPediatrics Corp. (KIDS) has received a Silver metal designation in the "COVID Stops Here" campaign for achieving an 80%+ vaccination rate at its Indiana headquarters. This recognition highlights the importance of widespread vaccinations in combatting COVID-19, particularly the Delta variant. OrthoPediatrics' President emphasized the company's commitment to the health and safety of its employees throughout the pandemic. The campaign, promoted by the Indiana Chamber of Commerce, aims to encourage more organizations to prioritize COVID-19 vaccinations.
OrthoPediatrics Corp. (KIDS) has announced preliminary third quarter 2021 revenue of approximately $25.1 million, a 13% increase from $22.2 million in the same period last year. However, the revenue was impacted by increased COVID-19 Delta variant cases and RSV cases affecting children's hospitals along with hospital staff shortages. The company maintains its 2021 total revenue guidance of $97 million to $101 million. These figures are preliminary and subject to audit adjustments.
A conference call is scheduled for November 4, 2021.
OrthoPediatrics Corp. (Nasdaq: KIDS) announced its Platinum-level sponsorship for the AACPDM Annual Meeting, occurring virtually from October 6-9, 2021. The company will provide scholarships, educational support, and showcase products at the event. OrthoPediatrics emphasizes its commitment to pediatric orthopedic education, having recently participated in the Scoliosis Research Society meeting and the POST Course, which trains orthopedic residents in pediatric surgical techniques. President David Bailey highlighted the positive impact of their educational support in advancing the field.
OrthoPediatrics Corp. (Nasdaq: KIDS) has announced a 5-year exclusive distribution agreement with SeaSpine Orthopedics to distribute the 7D Surgical FLASH™ Navigation platform for pediatric applications. This agreement allows OrthoPediatrics to enhance surgical workflows and patient safety in pediatric orthopedic surgeries by utilizing radiation-free technology. The FLASH Navigation system, featuring innovative camera-based technology, eliminates the need for intra-operative CT and fluoroscopy, significantly reducing radiation exposure. This partnership aligns with OrthoPediatrics' commitment to pediatric orthopedics and innovation.
FAQ
What is the current stock price of Orthopedia (KIDS)?
What is the market cap of Orthopedia (KIDS)?
